Cabaletta Bio 1 article

Cabaletta Bio is a cell-therapy biotechnology company whose scientific identity centers on autoimmune CAR-T therapy, with B-cell reset for autoimmune disease defining how the therapeutic cells are selected or engineered. Its cell-therapy architecture extends from systemic lupus erythematosus cell therapy to lupus nephritis cellular immunotherapy, with idiopathic inflammatory myopathy cell therapy shaping potency, persistence, targeting or immune compatibility. Specific cell types, genetic modifications and therapeutic products remain distinct tags; the cellular strategy of Cabaletta Bio also includes engineered T-cell autoimmunity platform.